Logo
Personalized Gene Therapy Treatments For Cancer Market
  2. / Market Insights
  3. Table of Content - Personalized Gene Therapy Treatments For Cancer Market Analysis
all report title image

Personalized Gene Therapy Treatments For Cancer Market, By Therapy Type (Viral Vector-Based, Non-Viral Vector-Based, CRISPR-Cas9 Based, RNA-Based, and Others), By Cancer Type (Hematologic Cancer, Solid Tumors, Rare Cancers, and Others), By End-User (Hospitals & Specialty Clinics, ResearchInstitutes, and Contract Development & Manufacturing Organizations(CDMOs)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : 07 Jan, 2026
  • Code : CMI60
  • Formats :
      Excel and PDF
  • Industry : Biotechnology
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions

    • Research Objectives

    • Assumptions

    • Abbreviations

  2. Market Preview

    • Report Description

      • Market Definition and Scope

    • Executive Summary

      • Market Snapshot, By Therapy Type

      • Market Snapshot, By Cancer Type

      • Market Snapshot, By End User

      • Market Snapshot, By Region

    • Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics

      • Drivers

      • Restraints

      • Market Opportunities

    • Impact Analysis

    • Recent Product Launches

    • Epidemiology

    • Merger, Acquisition, and Collaboration

    • Regulatory Scenario

    • Key Developments

    • PEST Analysis

    • Partnership Scenario

    • Brand and Pricing Analysis

    • Distributors Landscape

    • Porters Analysis

    • Technological Advancements

    • Key Developments

    • Market Trend

    • Future Prospective

    • Top Market Players by Revenue

  4. Personalized Gene Therapy Treatments For Cancer Market By Therapy Type, 2026–2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, 2022–2033

      • Segment Trends

    • Viral Vector-Based

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Non-Viral Vector-Based

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • CRISPR-Cas9 Based

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • RNA-Based

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  5. Personalized Gene Therapy Treatments For Cancer Market By Cancer Type, 2026-2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, 2022–2033

      • Segment Trends

    • Hematologic Cancer

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Solid Tumors

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Rare Cancers

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  6. Personalized Gene Therapy Treatments For Cancer Market By End User, 2026-2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, 2022–2033

      • Segment Trends

    • Hospitals & Specialty Clinics

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Research Institutes

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Contract Development & Manufacturing Organizations (CDMOs)

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  7. Personalized Gene Therapy Treatments For Cancer Market By Region, 2026-2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, By Region, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, For Regions, 2022–2033

      • Regional Trends

    • North America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, en2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        • U.S.

        • Canada

    • Latin America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        • U.K.

        • Germany

        • Italy

        • France

        • Spain

        • Russia

        • Benelux

        • Denmark

        • Norway

        • Sweden

        • Rest of Europe

    • Asia Pacific

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        • China

        • Taiwan

        • India

        • Japan

        • Indonesia

        • Malaysia

        • Philippines

        • Singapore

        • Australia

        • South Korea

        • Rest of Asia Pacific

o Middle East & Africa

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2026-2033, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2026-2033, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • UAE

    • Israel

    • South Africa

    • North Africa

    • Central Africa

    • Rest of the Middle East

  1. Competitive Landscape

    • Takeda Pharmaceutical

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Celyad Oncology

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Audentes Therapeutics

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • PTC Therapeutics

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Beam Therapeutics

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Moderna Therapeutics

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • MeiraGTx

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Regenxbio

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Homology Medicines

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • TCR2 Therapeutics

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

  2. Section

    • Research Methodology

    • About Us

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.